Moderna (XTER:0QF) Accumulated Depreciation : €-524 Mil (As of Mar. 2025)

View and export this data going back to 2020. Start your Free Trial

What is Moderna Accumulated Depreciation?

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

Moderna's quarterly accumulated depreciation increased from Sep. 2024 (€-496 Mil) to Dec. 2024 (€-503 Mil) and increased from Dec. 2024 (€-503 Mil) to Mar. 2025 (€-524 Mil).

Moderna's annual accumulated depreciation declined from Dec. 2022 (€-621 Mil) to Dec. 2023 (€-397 Mil) but then increased from Dec. 2023 (€-397 Mil) to Dec. 2024 (€-503 Mil).

Moderna Accumulated Depreciation Historical Data

The historical data trend for Moderna's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Moderna Accumulated Depreciation Chart

Moderna Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Accumulated Depreciation

Get a 7-Day Free Trial

-98.64

-311.52

-621.15

-397.06

-503.29

Moderna Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Accumulated Depreciation	Get a 7-Day Free Trial															-427.80	-468.22	-496.45	-503.29	-523.55

Moderna Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.

Moderna Accumulated Depreciation Related Terms

Thank you for viewing the detailed overview of Moderna's Accumulated Depreciation provided by GuruFocus.com. Please click on the following links to see related term pages.

Moderna Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Moderna Inc (XTER:0QF) » Definitions » Accumulated Depreciation

Comparable Companies

Traded in Other Exchanges

MRNA:USA MRNA:Mexico 1MRNA:Italy 0QFd:UK 0A45:UK M1RN34:Brazil 0QF:Bulgaria MRNA:Austria

Address

325 Binney Street, Cambridge, MA, USA, 02139

Website

https://www.modernatx.com

Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.

Moderna Headlines

No Headlines